180 related articles for article (PubMed ID: 37842346)
21. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
23. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
Mironova M; Ehrlich AC; Grinspan A; Protano MA
J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
[TBL] [Abstract][Full Text] [Related]
24. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
Suchman K; Luo Y; Grinspan A
Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
[TBL] [Abstract][Full Text] [Related]
25. [Faecal microbiota transplantation for Clostridioides difficile infection].
Waldbaum C; López F; Antelo P; Sorda J
Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
[TBL] [Abstract][Full Text] [Related]
26. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
Tariq R; Hayat M; Pardi D; Khanna S
Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893
[TBL] [Abstract][Full Text] [Related]
27. Fecal Microbiota Transplant in Severe and Non-Severe
Popa D; Neamtu B; Mihalache M; Boicean A; Banciu A; Banciu DD; Moga DFC; Birlutiu V
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945118
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
[TBL] [Abstract][Full Text] [Related]
29. Faecal microbiota transplantation for treatment of recurrent or refractory
Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
[TBL] [Abstract][Full Text] [Related]
30. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
31. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
[TBL] [Abstract][Full Text] [Related]
32. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
[TBL] [Abstract][Full Text] [Related]
34. Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection.
Paaske SE; Baumwall SMD; Rubak T; Birn FH; Rågård N; Kelsen J; Hansen MM; Svenningsen L; Krarup AL; Fernis CMC; Neumann A; Lødrup AB; Glerup H; Vinter-Jensen L; Helms M; Erikstrup LT; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38871148
[TBL] [Abstract][Full Text] [Related]
35. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
[TBL] [Abstract][Full Text] [Related]
36. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
37. Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory
Cheng YW; Fischer M
Clin Colon Rectal Surg; 2020 Mar; 33(2):92-97. PubMed ID: 32104162
[TBL] [Abstract][Full Text] [Related]
38. Faecal microbiota transplantation for recurrent
Baunwall SMD; Lee MM; Eriksen MK; Mullish BH; Marchesi JR; Dahlerup JF; Hvas CL
EClinicalMedicine; 2020 Dec; 29-30():100642. PubMed ID: 33437951
[TBL] [Abstract][Full Text] [Related]
39. Early Results of Fecal Microbial Transplantation Protocol Implementation at a Community-based University Hospital.
Duarte-Chavez R; Wojda TR; Zanders TB; Geme B; Fioravanti G; Stawicki SP
J Glob Infect Dis; 2018; 10(2):47-57. PubMed ID: 29910564
[TBL] [Abstract][Full Text] [Related]
40. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
